← FDA DRUG APPROVALS

FDA NDA · NDA021609

ENJUVIA

Sponsor: DURAMED

APPLICATION
NDA021609
TYPE
NDA
ORIGINAL APPROVAL
2004-12-20
LATEST ACTION
2004-12-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ENJUVIADiscontinued
ESTROGENS, CONJUGATED SYNTHETIC B 0.45MG · TABLET · ORAL
ENJUVIADiscontinued
ESTROGENS, CONJUGATED SYNTHETIC B 0.3MG · TABLET · ORAL

Approval history

2004-12-20Type 6 - New Indication (no longer used) · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →